Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
4.580
+0.060 (1.33%)
Nov 21, 2024, 12:03 PM EST - Market open
Sagimet Biosciences Market Cap
Sagimet Biosciences has a market cap or net worth of $146.17 million as of November 21, 2024. Its market cap has increased by 73.63% in one year.
Market Cap
146.17M
Enterprise Value
-25.59M
1-Year Change
73.63%
Ranking
Category
Stock Price
$4.58
Market Cap Chart
Since the IPO on July 14, 2023, Sagimet Biosciences's market cap has decreased from $354.80M to $146.17M, a decrease of -58.80%. That is a compound annual growth rate of -48.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 144.25M | 16.24% |
| Dec 29, 2023 | 124.10M | -65.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Myomo | 143.37M |
| Cardiol Therapeutics | 143.33M |
| Achieve Life Sciences | 143.06M |
| Adverum Biotechnologies | 142.50M |
| Black Diamond Therapeutics | 141.46M |
| Vaxart | 138.74M |
| Skye Bioscience | 138.34M |
| Sensus Healthcare | 137.83M |